TC 927 - Advancements in precision oncology and therapy

The session will review the role of imaging biomarkers in detection and characterisation of prostate cancer, guidance of personalised treatment planning, prediction and assessment of response to therapy, and detection of disease recurrence. It will review the emerging image-guided focal therapies as methods for personalised treatment of prostate cancer based on risk criteria and optimisation of oncologic and life quality outcomes. It aims to discuss the role of theranostic agents in the treatment of prostate cancer.